{"transactions":[{"id":1273786,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":83363,"kind":"person","name":"Ezickson Elan","position":1,"cik":"0001486429","reported_name":"Ezickson Elan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-11T09:19:58.000Z","date":"2025-02-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":7.12,"expiration_date":"2029-12-11","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-25-011248","document":"tm255946-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1486429/000110465925011248/tm255946-10_4seq1.xml","form_type":"4"}},{"id":1273785,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":83363,"kind":"person","name":"Ezickson Elan","position":1,"cik":"0001486429","reported_name":"Ezickson Elan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-11T09:19:58.000Z","date":"2025-02-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":12.6,"expiration_date":"2031-01-15","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001104659-25-011248","document":"tm255946-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1486429/000110465925011248/tm255946-10_4seq1.xml","form_type":"4"}},{"id":1273784,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":83363,"kind":"person","name":"Ezickson Elan","position":1,"cik":"0001486429","reported_name":"Ezickson Elan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-11T09:19:58.000Z","date":"2025-02-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":12375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":10.4,"expiration_date":"2032-02-04","underlying":"Common Stock","underlying_shares":12375},"source":{"system":"sec-edgar","filing":"0001104659-25-011248","document":"tm255946-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1486429/000110465925011248/tm255946-10_4seq1.xml","form_type":"4"}},{"id":1273783,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":83363,"kind":"person","name":"Ezickson Elan","position":1,"cik":"0001486429","reported_name":"Ezickson Elan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-11T09:19:58.000Z","date":"2025-02-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":16200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":5.94,"expiration_date":"2033-01-26","underlying":"Common Stock","underlying_shares":16200},"source":{"system":"sec-edgar","filing":"0001104659-25-011248","document":"tm255946-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1486429/000110465925011248/tm255946-10_4seq1.xml","form_type":"4"}},{"id":1273782,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":83363,"kind":"person","name":"Ezickson Elan","position":1,"cik":"0001486429","reported_name":"Ezickson Elan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-11T09:19:58.000Z","date":"2025-02-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":9.74,"expiration_date":"2034-01-18","underlying":"Common Stock","underlying_shares":20900},"source":{"system":"sec-edgar","filing":"0001104659-25-011248","document":"tm255946-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1486429/000110465925011248/tm255946-10_4seq1.xml","form_type":"4"}},{"id":1273781,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":83363,"kind":"person","name":"Ezickson Elan","position":1,"cik":"0001486429","reported_name":"Ezickson Elan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-11T09:19:58.000Z","date":"2025-02-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":1.4,"expiration_date":"2034-06-18","underlying":"Common Stock","underlying_shares":10450},"source":{"system":"sec-edgar","filing":"0001104659-25-011248","document":"tm255946-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1486429/000110465925011248/tm255946-10_4seq1.xml","form_type":"4"}},{"id":1273780,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":83363,"kind":"person","name":"Ezickson Elan","position":1,"cik":"0001486429","reported_name":"Ezickson Elan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-11T09:19:58.000Z","date":"2025-02-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2300,"price":0.55,"value":1265.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 29, 2024, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Immedica Pharma AB, a corporation organized and existing under the laws of Sweden (\"Parent\"), and Matador Subsidiary, Inc. a Delaware corporation and a wholly owned subsidiary of Parent (\"Purchaser\"). Pursuant to the terms of the Merger Agreement and the Offer (as defined in the Merger Agreement), each share of the Issuer's common stock (the \"Common Stock\") held by the Reporting Person was acquired, subject to adjustment, at a purchase price of $0.55 per share (the \"Offer Price\") in cash."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents 2,300 shares underlying Restricted Stock Units (the \"RSUs\"). Pursuant to the terms of the Merger Agreement, at the effective time of the merger (the \"Effective Time\"), each outstanding RSU was terminated in exchange for a lump sum cash payment equal to (i) the Offer Price multiplied by (ii) the number of shares of Common Stock underlying the RSU."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 29, 2024, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Immedica Pharma AB, a corporation organized and existing under the laws of Sweden (\"Parent\"), and Matador Subsidiary, Inc. a Delaware corporation and a wholly owned subsidiary of Parent (\"Purchaser\"). Pursuant to the terms of the Merger Agreement and the Offer (as defined in the Merger Agreement), each share of the Issuer's common stock (the \"Common Stock\") held by the Reporting Person was acquired, subject to adjustment, at a purchase price of $0.55 per share (the \"Offer Price\") in cash."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-25-011248","document":"tm255946-10_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1486429/000110465925011248/tm255946-10_4seq1.xml","form_type":"4"}},{"id":1273779,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":83363,"kind":"person","name":"Ezickson Elan","position":1,"cik":"0001486429","reported_name":"Ezickson Elan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-11T09:19:58.000Z","date":"2025-02-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8600,"price":0.55,"value":4730.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 29, 2024, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Immedica Pharma AB, a corporation organized and existing under the laws of Sweden (\"Parent\"), and Matador Subsidiary, Inc. a Delaware corporation and a wholly owned subsidiary of Parent (\"Purchaser\"). Pursuant to the terms of the Merger Agreement and the Offer (as defined in the Merger Agreement), each share of the Issuer's common stock (the \"Common Stock\") held by the Reporting Person was acquired, subject to adjustment, at a purchase price of $0.55 per share (the \"Offer Price\") in cash."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 29, 2024, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Immedica Pharma AB, a corporation organized and existing under the laws of Sweden (\"Parent\"), and Matador Subsidiary, Inc. a Delaware corporation and a wholly owned subsidiary of Parent (\"Purchaser\"). Pursuant to the terms of the Merger Agreement and the Offer (as defined in the Merger Agreement), each share of the Issuer's common stock (the \"Common Stock\") held by the Reporting Person was acquired, subject to adjustment, at a purchase price of $0.55 per share (the \"Offer Price\") in cash."}],"balance_after":2300,"source":{"system":"sec-edgar","filing":"0001104659-25-011248","document":"tm255946-10_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1486429/000110465925011248/tm255946-10_4seq1.xml","form_type":"4"}},{"id":1296322,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":83363,"kind":"person","name":"Ezickson Elan","position":1,"cik":"0001486429","reported_name":"Ezickson Elan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-23T16:17:32.000Z","date":"2025-01-21","kind":"sale","planned":true,"acquired":false,"shares":1600,"price":0.54,"value":864.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares of common stock of Marinus Pharmaceuticals, Inc. (the \"Company\") sold by the reporting person pursuant to a Rule 10b5-1 Plan adopted on March 10, 2024 to cover tax obligations in connection with the vesting of restricted stock units."}],"balance_after":10900,"source":{"system":"sec-edgar","filing":"0001415889-25-001930","document":"form4-01232025_090128.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1486429/000141588925001930/form4-01232025_090128.xml","form_type":"4"}},{"id":1473123,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":83363,"kind":"person","name":"Ezickson Elan","position":1,"cik":"0001486429","reported_name":"Ezickson Elan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-20T16:23:51.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":10450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in full on July 15, 2025, subject to the reporting person's continued service with the Issuer."}],"balance_after":10450,"derivative":{"exercise_price":1.4,"expiration_date":"2034-06-18","underlying":"Common Stock","underlying_shares":10450},"source":{"system":"sec-edgar","filing":"0001415889-24-017634","document":"form4-06202024_080645.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1486429/000141588924017634/form4-06202024_080645.xml","form_type":"4"}},{"id":1473122,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":83363,"kind":"person","name":"Ezickson Elan","position":1,"cik":"0001486429","reported_name":"Ezickson Elan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-20T16:23:51.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":2300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (RSUs). The RSUs vest in full on July 15, 2025, subject to the reporting person's continued service with Marinus Pharmaceuticals, Inc. (the Issuer). Each RSU represents the right to receive one share of common stock of the Issuer."}],"balance_after":12500,"source":{"system":"sec-edgar","filing":"0001415889-24-017634","document":"form4-06202024_080645.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1486429/000141588924017634/form4-06202024_080645.xml","form_type":"4"}},{"id":1675163,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":83363,"kind":"person","name":"Ezickson Elan","position":1,"cik":"0001486429","reported_name":"Ezickson Elan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-19T16:26:31.000Z","date":"2024-01-18","kind":"grant","planned":false,"acquired":true,"shares":20900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in 12 equal monthly installments beginning on February 18, 2024, subject to the reporting person's continued service with the Issuer."}],"balance_after":20900,"derivative":{"exercise_price":9.74,"expiration_date":"2034-01-18","underlying":"Common Stock","underlying_shares":20900},"source":{"system":"sec-edgar","filing":"0001415889-24-001600","document":"form4-01192024_090126.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1486429/000141588924001600/form4-01192024_090126.xml","form_type":"4"}},{"id":1675162,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":83363,"kind":"person","name":"Ezickson Elan","position":1,"cik":"0001486429","reported_name":"Ezickson Elan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-19T16:26:31.000Z","date":"2024-01-18","kind":"grant","planned":false,"acquired":true,"shares":4600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (RSUs). The RSUs vest in full on January 18, 2024, subject to the reporting person's continued service with Marinus Pharmaceuticals, Inc. (the Issuer). Each RSU represents the right to receive one share of common stock of the Issuer."}],"balance_after":10200,"source":{"system":"sec-edgar","filing":"0001415889-24-001600","document":"form4-01192024_090126.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1486429/000141588924001600/form4-01192024_090126.xml","form_type":"4"}},{"id":2026478,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":83363,"kind":"person","name":"Ezickson Elan","position":1,"cik":"0001486429","reported_name":"Ezickson Elan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-08T16:36:40.000Z","date":"2023-02-06","kind":"sale","acquired":false,"shares":750,"price":6.56,"value":4920.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares of common stock of Marinus Pharmaceuticals, Inc. (the \"Company\") sold by the reporting person pursuant to a Rule 10b5-1 plan to cover tax obligations in connection with the vesting of previously granted restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $6.55 - $6.56, inclusive. The\nreporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":5600,"source":{"system":"sec-edgar","filing":"0001415889-23-002162","document":"form4-02082023_090232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1486429/000141588923002162/form4-02082023_090232.xml","form_type":"4"}},{"id":2042110,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":83363,"kind":"person","name":"Ezickson Elan","position":1,"cik":"0001486429","reported_name":"Ezickson Elan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-30T16:26:16.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":16200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in 12 equal monthly installments beginning on February 26, 2023, subject to the reporting person's continued service with the Issuer."}],"balance_after":16200,"derivative":{"exercise_price":5.94,"expiration_date":"2033-01-26","underlying":"Common Stock","underlying_shares":16200},"source":{"system":"sec-edgar","filing":"0001415889-23-001560","document":"form4-01302023_090107.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1486429/000141588923001560/form4-01302023_090107.xml","form_type":"4"}},{"id":2042109,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":83363,"kind":"person","name":"Ezickson Elan","position":1,"cik":"0001486429","reported_name":"Ezickson Elan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-30T16:26:16.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":3600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (RSUs). The RSUs vest in full on January 26, 2024, subject to the reporting person's continued service with Marinus Pharmaceuticals, Inc. (the Issuer). Each RSU represents the right to receive one share of common stock of the Issuer."}],"balance_after":6350,"source":{"system":"sec-edgar","filing":"0001415889-23-001560","document":"form4-01302023_090107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1486429/000141588923001560/form4-01302023_090107.xml","form_type":"4"}},{"id":2410066,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":83363,"kind":"person","name":"Ezickson Elan","position":1,"cik":"0001486429","reported_name":"Ezickson Elan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-07T16:09:54.000Z","date":"2022-02-04","kind":"grant","acquired":true,"shares":12375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable monthly over 12 months beginning on March 4, 2022."}],"balance_after":12375,"derivative":{"exercise_price":10.4,"expiration_date":"2032-02-04","underlying":"Common Stock","underlying_shares":12375},"source":{"system":"sec-edgar","filing":"0001104659-22-012783","document":"tm225605-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1486429/000110465922012783/tm225605-5_4seq1.xml","form_type":"4"}},{"id":2410065,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":83363,"kind":"person","name":"Ezickson Elan","position":1,"cik":"0001486429","reported_name":"Ezickson Elan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-07T16:09:54.000Z","date":"2022-02-04","kind":"grant","acquired":true,"shares":2750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (RSUs). The RSUs vest in full on February 4, 2023, subject to the reporting person's continued service with Marinus Pharmaceuticals, Inc. (the Issuer). Each RSU represents the right to receive one share of common stock of the Issuer."}],"balance_after":2750,"source":{"system":"sec-edgar","filing":"0001104659-22-012783","document":"tm225605-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1486429/000110465922012783/tm225605-5_4seq1.xml","form_type":"4"}},{"id":2904289,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":83363,"kind":"person","name":"Ezickson Elan","position":1,"cik":"0001486429","reported_name":"Ezickson Elan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-01-19T20:13:12.000Z","date":"2021-01-15","kind":"grant","acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase shares of common stock vest in 12 equal monthly installments, commencing on 1/31/21."}],"balance_after":16500,"derivative":{"exercise_price":12.6,"expiration_date":"2031-01-15","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001104659-21-005519","document":"tm213599-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1486429/000110465921005519/tm213599-5_4seq1.xml","form_type":"4"}},{"id":3323838,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":83363,"kind":"person","name":"Ezickson Elan","position":1,"cik":"0001486429","reported_name":"Ezickson Elan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-03T22:06:57.000Z","date":"2019-12-31","kind":"tax_withholding","acquired":false,"shares":40107,"price":4.72,"value":189305.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of a restricted stock grant."}],"balance_after":71887,"source":{"system":"sec-edgar","filing":"0001209191-20-001171","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919120001171/doc4.xml","form_type":"4"}},{"id":3323837,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":83363,"kind":"person","name":"Ezickson Elan","position":1,"cik":"0001486429","reported_name":"Ezickson Elan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-03T22:06:57.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":31780,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"31,780 shares vest on 12/31/2020."}],"balance_after":111994,"source":{"system":"sec-edgar","filing":"0001209191-20-001171","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919120001171/doc4.xml","form_type":"4"}},{"id":3342268,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":83363,"kind":"person","name":"Ezickson Elan","position":1,"cik":"0001486429","reported_name":"Ezickson Elan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2019-12-13T16:06:46.000Z","date":"2019-12-11","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase shares of common stock vest monthly in 36 equal installments beginning 1/1/20."}],"balance_after":100000,"derivative":{"exercise_price":1.78,"expiration_date":"2029-12-11","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-19-072570","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1486429/000110465919072570/a4.xml","form_type":"4"}},{"id":3714463,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":83363,"kind":"person","name":"Ezickson Elan","position":1,"cik":"0001486429","reported_name":"Ezickson Elan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-03T02:16:19.000Z","date":"2018-12-31","kind":"grant","acquired":true,"shares":80214,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"80,214 shares vest on 12/31/2019."}],"balance_after":80214,"source":{"system":"sec-edgar","filing":"0001209191-19-000587","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919119000587/doc4.xml","form_type":"4"}},{"id":3810894,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":83363,"kind":"person","name":"Ezickson Elan","position":1,"cik":"0001486429","reported_name":"Ezickson Elan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-09-20T20:15:30.000Z","date":"2018-09-18","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25,000 shares shall vest on each of 9/18/2019 and 9/18/2020."}],"balance_after":50000,"derivative":{"exercise_price":3,"expiration_date":"2028-09-18","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-18-051785","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919118051785/doc4.xml","form_type":"4"}},{"id":3912618,"issuer":{"id":3721,"kind":"organization","name":"Scholar Rock Holding Corp","symbol":"SRRK"},"owners":[{"id":83363,"kind":"person","name":"Ezickson Elan","position":1,"cik":"0001486429","reported_name":"Ezickson Elan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & Head of Corp.Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-01T01:41:52.000Z","date":"2018-05-29","kind":"grant","acquired":true,"shares":8757,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vested in full upon the closing of the Issuer's initial public offering on May 29, 2018.  The performance criteria for the entire option grant of 8,757 shares was met, resulting in the full vesting of the option."}],"balance_after":8757,"derivative":{"exercise_price":5.77,"expiration_date":"2028-02-20","underlying":"Common Stock","underlying_shares":8757},"source":{"system":"sec-edgar","filing":"0001104659-18-037314","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727196/000110465918037314/a4.xml","form_type":"4"}}]}